These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6204904)

  • 21. Effects of serum from trypsin inhibitor fed rats on enzyme secretion and protein synthesis by exocrine pancreatic cells.
    Toregard BM; Ihse I; Nilsson A
    Scand J Clin Lab Invest; 1983 Dec; 43(8):735-8. PubMed ID: 6198713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma cholecystokinin concentration in patients with chronic pancreatitis measured by bioassay].
    Koide M; Okabayashi Y; Hasegawa H; Tani S; Fujisawa T; Nakamura T; Fujii M; Otsuki M
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2419-24. PubMed ID: 2480463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism.
    Obourn JD; Frame SR; Chiu T; Solomon TE; Cook JC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):116-26. PubMed ID: 9299603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic dietary Cu(2+)-deficiency alters cholecystokinin signal transduction in isolated rat pancreatic acini.
    Miller ST; McCullough SS; Chowdhury P; Blevins GT
    J Assoc Acad Minor Phys; 2000; 11(2-3):21-7. PubMed ID: 10953540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCK-58 is the only detectable endocrine form of cholecystokinin in rat.
    Reeve JR; Green GM; Chew P; Eysselein VE; Keire DA
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G255-65. PubMed ID: 12686511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of pancreatic secretion and growth in the rat after feeding cholestyramine.
    Brand SJ; Morgan RG
    Gastroenterology; 1982 Oct; 83(4):851-9. PubMed ID: 7106515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-type natriuretic peptide enhances amylase release through NPR-C receptors in the exocrine pancreas.
    Sabbatini ME; Rodríguez M; di Carlo MB; Davio CA; Vatta MS; Bianciotti LG
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G987-94. PubMed ID: 17702953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides.
    Robberecht P; Deschodt-Lanckman M; Woussen-Colle MC; De Neef P; Camus JC; Christophe J
    Mol Pharmacol; 1980 Mar; 17(2):268-74. PubMed ID: 6156397
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
    Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The release of rat intestinal cholecystokinin after oral trypsin inhibitor measured by bio-assay.
    Brand SJ; Morgan RG
    J Physiol; 1981; 319():325-43. PubMed ID: 7320918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short-term effects of feeding crude soybean trypsin inhibitor on pancreas of rat, hamster and mouse].
    Furukawa F; Toyoda K; Abe H; Hasegawa R; Sato H; Takahashi M; Hayashi Y
    Eisei Shikenjo Hokoku; 1987; (105):46-50. PubMed ID: 3449168
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cholecystokinin and the mechanism of negative feedback of pancreatic enzyme secretion: animal experiment findings in the rat; possible significance for human physiology].
    Wilms HM
    Z Gastroenterol Verh; 1988 Apr; 23():190-3. PubMed ID: 2454551
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassay.
    Mössner J; Zeeh JM; Eberlein G; Schäffer M; Regner U; Grandt D; Goebell H; Eysselein VE
    Digestion; 1991; 48(4):210-9. PubMed ID: 1724764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of dietary protein and trypsin inhibitor on plasma cholecystokinin and pancreatic growth in rats.
    Green GM; Levan VH; Liddle RA
    Adv Exp Med Biol; 1986; 199():123-32. PubMed ID: 3799272
    [No Abstract]   [Full Text] [Related]  

  • 35. Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini.
    Miyasaka K; Funakoshi A; Matsumoto M; Nakamura R; Sakamoto S; Sakai H; Kitani K
    Dig Dis Sci; 1991 Mar; 36(3):310-6. PubMed ID: 1995267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptation of the pancreas during treatment with enzyme inhibitors in rats and man.
    Fölsch UR; Creutzfeldt W
    Scand J Gastroenterol Suppl; 1985; 112():54-63. PubMed ID: 2409582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the action of cholecystokinin octapeptide on the guinea pig ileum myenteric plexus by dibutyryl cyclic guanosine monophosphate.
    Hutchison JB; Dockray GJ
    Brain Res; 1980 Dec; 202(2):501-5. PubMed ID: 6254616
    [No Abstract]   [Full Text] [Related]  

  • 38. Inactivation of cholecystokinin receptors in rat pancreatic membranes by sulfhydryl reagents: protection by guanosine 5'-triphosphate (GTP) but not N2,O2-dibutyryl guanosine 3',5'-cyclic monophosphate (dibutyryl cGMP).
    Chang RS; Lotti VJ; Chen TB
    Biochem Pharmacol; 1984 Jul; 33(14):2334-5. PubMed ID: 6087823
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of ethanol on pancreatic enzyme secretion.
    Valenzuela JE; Salinas J; Petermann M
    Gastroenterology; 1974 Nov; 67(5):991-5. PubMed ID: 4426498
    [No Abstract]   [Full Text] [Related]  

  • 40. Amylase secretion by rat pancreas following prolonged stimulation by unheated soybean flour.
    Konijn AM; Eyal Z; Birnbaum D; Guggenheim K
    Digestion; 1972; 6(6):330-7. PubMed ID: 4673998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.